October 25,2010
Grassley Asks FDA about Medical Device Company Payments to Doctors in Clinical Studies
WASHINGTON – On Friday, Sen. Chuck Grassley of Iowa asked the Food and Drug Administration how the agency handles reports of medical device companies' payments to doctors who are participating in clinical studies of the companies' products.
Grassley wrote to the FDA commissioner, citing information that doctors participating in clinical trials sponsored by a particular medical device maker also received significant payments from that device maker.
“The FDA should be transparent and describe what it does with information about potential conflicts of interest, including any steps it takes to protect the integrity and reliability of clinical research,” Grassley said.
Next Article Previous Article
Recent News
- Wyden Praises Trade Court Decision Striking Down Trump’s Illegal Global Tariffs
- Wyden Statement on House Passage of Reconciliation Legislation
- Wyden Warns Republicans that Overruling Parliamentarian to Nix California Clean Air Waiver Will Backfire
- Wyden Statement on IRS Nominee Billy Long's Involvement in Tax Scams
- Wyden Opposes HHS Nominees O'Neill and Andres to be Deputy Secretary and Congressional Liaison